Literature DB >> 21619629

Evidence for a heritable predisposition to Chronic Fatigue Syndrome.

Frederick Albright1, Kathleen Light, Alan Light, Lucinda Bateman, Lisa A Cannon-Albright.   

Abstract

BACKGROUND: Chronic Fatigue Syndrome (CFS) came to attention in the 1980s, but initial investigations did not find organic causes. Now decades later, the etiology of CFS has yet to be understood, and the role of genetic predisposition in CFS remains controversial. Recent reports of CFS association with the retrovirus xenotropic murine leukemic virus-related virus (XMRV) or other murine leukemia related retroviruses (MLV) might also suggest underlying genetic implications within the host immune system.
METHODS: We present analyses of familial clustering of CFS in a computerized genealogical resource linking multiple generations of genealogy data with medical diagnosis data of a large Utah health care system. We compare pair-wise relatedness among cases to expected relatedness in the Utah population, and we estimate risk for CFS for first, second, and third degree relatives of CFS cases.
RESULTS: We observed significant excess relatedness of CFS cases compared to that expected in this population. Significant excess relatedness was observed for both close (p <0.001) and distant relationships (p = 0.010). We also observed significant excess CFS relative risk among first (2.70, 95% CI: 1.56-4.66), second (2.34, 95% CI: 1.31-4.19), and third degree relatives (1.93, 95% CI: 1.21-3.07).
CONCLUSIONS: These analyses provide strong support for a heritable contribution to predisposition to Chronic Fatigue Syndrome. A population of high-risk CFS pedigrees has been identified, the study of which may provide additional understanding.

Entities:  

Mesh:

Year:  2011        PMID: 21619629      PMCID: PMC3128000          DOI: 10.1186/1471-2377-11-62

Source DB:  PubMed          Journal:  BMC Neurol        ISSN: 1471-2377            Impact factor:   2.474


  38 in total

1.  A twin study of the etiology of prolonged fatigue and immune activation.

Authors:  I B Hickie; A S Bansal; K M Kirk; A R Lloyd; N G Martin
Journal:  Twin Res       Date:  2001-04

2.  The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group.

Authors:  K Fukuda; S E Straus; I Hickie; M C Sharpe; J G Dobbins; A Komaroff
Journal:  Ann Intern Med       Date:  1994-12-15       Impact factor: 25.391

3.  Severity of symptom flare after moderate exercise is linked to cytokine activity in chronic fatigue syndrome.

Authors:  Andrea T White; Alan R Light; Ronald W Hughen; Lucinda Bateman; Thomas B Martins; Harry R Hill; Kathleen C Light
Journal:  Psychophysiology       Date:  2010-03-04       Impact factor: 4.016

4.  Twin analyses of chronic fatigue in a Swedish national sample.

Authors:  Patrick F Sullivan; Birgitta Evengård; Andreas Jacks; Nancy L Pedersen
Journal:  Psychol Med       Date:  2005-09       Impact factor: 7.723

5.  Chronic fatigue syndrome: occupation, medical utilization, and subtypes in a community-based sample.

Authors:  L A Jason; R R Taylor; C L Kennedy; S Song; D Johnson; S Torres
Journal:  J Nerv Ment Dis       Date:  2000-09       Impact factor: 2.254

6.  The epidemiology of chronic fatigue in San Francisco.

Authors:  L Steele; J G Dobbins; K Fukuda; M Reyes; B Randall; M Koppelman; W C Reeves
Journal:  Am J Med       Date:  1998-09-28       Impact factor: 4.965

7.  Absence of evidence of xenotropic murine leukemia virus-related virus infection in persons with chronic fatigue syndrome and healthy controls in the United States.

Authors:  William M Switzer; Hongwei Jia; Oliver Hohn; HaoQiang Zheng; Shaohua Tang; Anupama Shankar; Norbert Bannert; Graham Simmons; R Michael Hendry; Virginia R Falkenberg; William C Reeves; Walid Heneine
Journal:  Retrovirology       Date:  2010-07-01       Impact factor: 4.602

8.  A genealogical assessment of heritable predisposition to asthma mortality.

Authors:  Craig C Teerlink; Matthew J Hegewald; Lisa A Cannon-Albright
Journal:  Am J Respir Crit Care Med       Date:  2007-08-09       Impact factor: 21.405

Review 9.  The HPA axis and the genesis of chronic fatigue syndrome.

Authors:  Anthony J Cleare
Journal:  Trends Endocrinol Metab       Date:  2004-03       Impact factor: 12.015

10.  The economic impact of ME/CFS: individual and societal costs.

Authors:  Leonard A Jason; Mary C Benton; Lisa Valentine; Abra Johnson; Susan Torres-Harding
Journal:  Dyn Med       Date:  2008-04-08
View more
  24 in total

Review 1.  Biomarkers for chronic fatigue.

Authors:  Nancy G Klimas; Gordon Broderick; Mary Ann Fletcher
Journal:  Brain Behav Immun       Date:  2012-06-23       Impact factor: 7.217

2.  Risk of associated conditions in relatives of subjects with interstitial cystitis.

Authors:  Kristina Allen-Brady; Peggy A Norton; Lisa Cannon-Albright
Journal:  Female Pelvic Med Reconstr Surg       Date:  2015 Mar-Apr       Impact factor: 2.091

3.  No replication of previously reported association with genetic variants in the T cell receptor alpha (TRA) locus for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).

Authors:  Marthe Ueland; Riad Hajdarevic; Olav Mella; Elin B Strand; Daisy D Sosa; Ola D Saugstad; Øystein Fluge; Benedicte A Lie; Marte K Viken
Journal:  Transl Psychiatry       Date:  2022-07-11       Impact factor: 7.989

4.  Genetic risk factors of ME/CFS: a critical review.

Authors:  Joshua J Dibble; Simon J McGrath; Chris P Ponting
Journal:  Hum Mol Genet       Date:  2020-09-30       Impact factor: 6.150

Review 5.  Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Diagnosis and Management in Young People: A Primer.

Authors:  Peter C Rowe; Rosemary A Underhill; Kenneth J Friedman; Alan Gurwitt; Marvin S Medow; Malcolm S Schwartz; Nigel Speight; Julian M Stewart; Rosamund Vallings; Katherine S Rowe
Journal:  Front Pediatr       Date:  2017-06-19       Impact factor: 3.418

6.  B-Lymphocyte Depletion in Myalgic Encephalopathy/ Chronic Fatigue Syndrome. An Open-Label Phase II Study with Rituximab Maintenance Treatment.

Authors:  Øystein Fluge; Kristin Risa; Sigrid Lunde; Kine Alme; Ingrid Gurvin Rekeland; Dipak Sapkota; Einar Kleboe Kristoffersen; Kari Sørland; Ove Bruland; Olav Dahl; Olav Mella
Journal:  PLoS One       Date:  2015-07-01       Impact factor: 3.240

Review 7.  A review of hypothalamic-pituitary-adrenal axis function in chronic fatigue syndrome.

Authors:  Cara Tomas; Julia Newton; Stuart Watson
Journal:  ISRN Neurosci       Date:  2013-09-30

8.  Genome-wide association analysis identifies genetic variations in subjects with myalgic encephalomyelitis/chronic fatigue syndrome.

Authors:  K A Schlauch; S F Khaiboullina; K L De Meirleir; S Rawat; J Petereit; A A Rizvanov; N Blatt; T Mijatovic; D Kulick; A Palotás; V C Lombardi
Journal:  Transl Psychiatry       Date:  2016-02-09       Impact factor: 6.222

9.  Serum BAFF and APRIL Levels, T-Lymphocyte Subsets, and Immunoglobulins after B-Cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Myalgic Encephalopathy/Chronic Fatigue Syndrome.

Authors:  Sigrid Lunde; Einar K Kristoffersen; Dipak Sapkota; Kristin Risa; Olav Dahl; Ove Bruland; Olav Mella; Øystein Fluge
Journal:  PLoS One       Date:  2016-08-18       Impact factor: 3.240

10.  Association of active human herpesvirus-6, -7 and parvovirus b19 infection with clinical outcomes in patients with myalgic encephalomyelitis/chronic fatigue syndrome.

Authors:  Svetlana Chapenko; Angelika Krumina; Inara Logina; Santa Rasa; Maksims Chistjakovs; Alina Sultanova; Ludmila Viksna; Modra Murovska
Journal:  Adv Virol       Date:  2012-08-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.